Chang S W, Zhang D, Chung H D, Zassenhaus H P
Department of Molecular Microbiology and Immunology, Department of Pathology, St. Louis University Health Sciences Center, 1402 South Grand Boulevard, St. Louis, Missouri 63104, USA.
Biochem Biophys Res Commun. 2000 Jun 24;273(1):203-8. doi: 10.1006/bbrc.2000.2885.
Using a PCR-based strategy, we found that point mutation frequencies in mitochondrial DNA (mtDNA) were 2- to 3-fold higher in the parietal gyrus, hippocampus, and cerebellum from subjects with Alzheimer's disease (AD) compared to normal controls. In contrast, levels of a commonly studied deletion mutation, mtDNA(4977), were not elevated in AD. The frequency of point mutations did not vary significantly among the three brain areas, whereas the frequency of mtDNA(4977) was 15- to 25-fold lower in the cerebellum in comparison to the cortex; this regional variation was seen in both the normal and Alzheimer's brain. In blood mtDNA, point mutation frequencies were not elevated in AD patients. The elevated frequency of point mutations in all three brain regions is consistent with the idea that increased oxidant stress is associated with AD.
采用基于聚合酶链反应(PCR)的策略,我们发现,与正常对照组相比,阿尔茨海默病(AD)患者顶叶回、海马体和小脑中的线粒体DNA(mtDNA)点突变频率高2至3倍。相比之下,一种常用的缺失突变mtDNA(4977)的水平在AD中并未升高。三个脑区之间的点突变频率没有显著差异,而与皮质相比,小脑中mtDNA(4977)的频率低15至25倍;这种区域差异在正常脑和AD脑中均可见。在血液mtDNA中,AD患者的点突变频率并未升高。所有三个脑区中点突变频率的升高与氧化应激增加与AD相关的观点一致。